Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Artemis 2 captures historic 'Earthset' photo | Space photo of the day for April 7, 2026 - 2As reefs vanish, assisted coral fertilization offers hope in the Dominican Republic
- 3The Best Computer games Ever
- 4Impact of NIH funding reductions felt in cancer and infectious disease trials
- 525 of the world’s best sandwiches
- Vote in favor of Your Number one BWM Vehicles
- Protest inspired by 'Gen Z' movement draws few young people in Mexico and many government critics
- AbbVie plans to build out its presence in obesity market
- Europe pledges over €15bn for clean energy for Africa
- Vote in favor of Your Number one Smartwatch: Exactness and Style Matter
- Vote In favor of Your Favored Menial helper Administration
- As her kidneys fail and time runs short, this activist fights to decriminalize euthanasia in Mexico
- How to see the Ursids, the final meteor shower of 2025
- Palestinians tell BBC they were sexually abused in Israeli prisons
